REMINYL NAME

Reminyl: Lawyer Seek Litigation - Pharmaceutical Injury Click here to contact an attorney regarding Reminyl , is marketed by Ortho-McNeil, a subsidiary of Johnson and Johnson. Galantamine has recently had its name changed in 2005 from Reminyl to Razadyne, in an effort to avoid confusion with the diabetes drug Amaryl. The name was changed after several instances of prescribing and dispensing errors were reported. Reminyl is a member of a class of drugs known as acetylcholinesterase inhibitors. Reminyl is designed to treat patients who suffer from mild to moderate cases of Alzheimer's disease. Alzheimer's disease is a condition where the patient has trouble with memory and thinking due to dying nerve cells in the brain. Alzheimer's is an extremely debilitating disease that affects millions of people and is also believed to be the leading cause of dementia. Reminyl is designed to work by protecting the chemical messenger known as acetylcholine from being destroyed. Acetylcholine is the chemical messenger responsible for cognitive skills and memory.